Tumor immunology & microenvironment

IL-6 Trans-Signaling in Metastasis & Immunotherapy Resistance

Mapping how the tumor's surroundings drive cancer spread — and why some patients stop responding to immunotherapy.

In submission
  • tumor microenvironment
  • metastasis
  • liver metastasis
  • immunotherapy resistance
  • IL-6
Graphical abstract — IL-6 trans-signalling in the tumour microenvironment driving liver metastasis and the split between immunotherapy response and resistance.

Cancer rarely acts alone. The tissue around a tumor — its microenvironment — can either help the immune system fight back or quietly enable the disease to spread and shrug off treatment. This research investigates IL-6 trans-signaling, a communication channel within that microenvironment, and its role in metastasis to the liver and in the resistance that blunts modern immunotherapies.

By clarifying how these signals reshape the battlefield between tumor and immune system, the work points toward strategies to keep immunotherapy working for more patients, for longer. The findings are under review at a leading journal in the field — a contribution to one of oncology’s hardest open questions: why some cancers respond and others do not, and how the answer might point to the next generation of combination strategies.

Partners & collaborators

← Back to all research